EDIT vs NI · rev $32.3M vs P/E 23, rev $5.28B
Editas Medicine Inc (EDIT) versus NiSource Inc (NI) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NI revenue for 2024-12-31 was $5.28B. Net income was $844.7M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. NI currently screens at market cap $22.42B and trailing P/E 23.3.
EDIT currently screens at market cap $375.2M. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Not investment advice. Open the EDIT and NI stock pages for the full models.
Not investment advice.